MustGrow Biologics (TSXV:MGRO) Additional Paid-In Capital : C$3.95 Mil(As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics Additional Paid-In Capital?

MustGrow Biologics's quarterly additional paid-in capital declined from Sep. 2023 (C$4.66 Mil) to Dec. 2023 (C$3.81 Mil) but then increased from Dec. 2023 (C$3.81 Mil) to Mar. 2024 (C$3.95 Mil).

MustGrow Biologics's annual additional paid-in capital increased from Dec. 2021 (C$2.46 Mil) to Dec. 2022 (C$3.82 Mil) but then declined from Dec. 2022 (C$3.82 Mil) to Dec. 2023 (C$3.81 Mil).

MustGrow Biologics Additional Paid-In Capital Historical Data

The historical data trend for MustGrow Biologics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics Additional Paid-In Capital Chart

MustGrow Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1.81

2.16

2.46

3.82

3.81

MustGrow Biologics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															3.82	3.89	4.66	3.81	3.95

MustGrow Biologics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

MustGrow Biologics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

MustGrow Biologics (TSXV:MGRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MGROF:USA 0C0:Germany

Address

1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5

Website

https://www.mustgrow.ca

MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.

Executives

Corey Joseph Giasson	Director, Senior Officer
Colin Michael Bletsky	Director

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines